# MEthylphenidate in ADHD - Addiction(s) Comorbidity: Value of Adding a Cognitive Remediation Program to Improve Short- and Medium-term Therapeutic Response

> **NCT06906328** · NA · RECRUITING · sponsor: **Nantes University Hospital** · enrollment: 248 (estimated)

## Conditions studied

- ADHD-add

## Interventions

- **BEHAVIORAL:** Cognitive remediation program, with the PRESCO® software
- **BEHAVIORAL:** Control program, with the AUDITICO® software

## Key facts

- **NCT ID:** NCT06906328
- **Lead sponsor:** Nantes University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-11
- **Primary completion:** 2028-12-11
- **Final completion:** 2029-12-11
- **Target enrollment:** 248 (ESTIMATED)
- **Last updated:** 2026-02-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06906328

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06906328, "MEthylphenidate in ADHD - Addiction(s) Comorbidity: Value of Adding a Cognitive Remediation Program to Improve Short- and Medium-term Therapeutic Response". Retrieved via AI Analytics 2026-09-25 from https://api.ai-analytics.org/clinical/NCT06906328. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*